Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia.
Yoshiyuki
Y
Takahashi
Hideki
H
Muramatsu
Naoki
N
Sakata
Nobuyuki
N
Hyakuna
Kazuko
K
Hamamoto
Ryoji
R
Kobayashi
Etsuro
E
Ito
Hiroshi
H
Yagasaki
Akira
A
Ohara
Akira
A
Kikuchi
Akira
A
Morimoto
Hiromasa
H
Yabe
Kazuko
K
Kudo
Ken-ichiro
K
Watanabe
Shouichi
S
Ohga
Seiji
S
Kojima
D000293:Adolescent; D000741:Anemia, Aplastic / Q000188:drug therapy* / Q000401:mortality*; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage* / Q000009:adverse effects; D044466:Asian People; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007223:Infant; D007564:Japan; D008297:Male; D011817:Rabbits; D012189:Retrospective Studies; D015996:Survival Rate
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine